Literature DB >> 1314783

Rescue of the adeno-associated virus 2 genome correlates with alterations in DNA-modifying enzymes in human cells.

P Nahreini1, A Srivastava.   

Abstract

The adeno-associated virus 2 (AAV) genome can be rescued either from a recombinant plasmid upon transfection into human cells or from cells latently infected with AAV, following subsequent infection with adenovirus. Using human diploid fibroblasts as a model for a natural AAV infection, we observed increased efficiency of rescue of the AAV genome in these cells as they traversed their limited proliferative life span in vitro. The efficiency of rescue correlated well with the augmented nuclease activity in these cells. Furthermore, rescue of the AAV genome, either from a recombinant plasmid or from the chromosomal DNA, was more efficient in cells from a patient with Bloom's syndrome, a rare autosomal recessive disease associated with increased chromosomal breakage due to DNA ligase I deficiency, as compared with normal human diploid fibroblasts. These studies suggest that alterations in DNA-modifying enzymes may play a role in rescue of the AAV genome in human cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1314783     DOI: 10.1159/000150239

Source DB:  PubMed          Journal:  Intervirology        ISSN: 0300-5526            Impact factor:   1.763


  9 in total

1.  Adeno-associated virus type 2-mediated transduction in primary human bone marrow-derived CD34+ hematopoietic progenitor cells: donor variation and correlation of transgene expression with cellular differentiation.

Authors:  S Ponnazhagan; P Mukherjee; X S Wang; K Qing; D M Kube; C Mah; C Kurpad; M C Yoder; E F Srour; A Srivastava
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

2.  Characterization of wild-type adeno-associated virus type 2-like particles generated during recombinant viral vector production and strategies for their elimination.

Authors:  X S Wang; B Khuntirat; K Qing; S Ponnazhagan; D M Kube; S Zhou; V J Dwarki; A Srivastava
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

3.  Rescue and autonomous replication of adeno-associated virus type 2 genomes containing Rep-binding site mutations in the viral p5 promoter.

Authors:  X S Wang; A Srivastava
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

4.  Rescue and replication of adeno-associated virus type 2 as well as vector DNA sequences from recombinant plasmids containing deletions in the viral inverted terminal repeats: selective encapsidation of viral genomes in progeny virions.

Authors:  X S Wang; S Ponnazhagan; A Srivastava
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

5.  Adeno-associated virus type 2 DNA replication in vivo: mutation analyses of the D sequence in viral inverted terminal repeats.

Authors:  X S Wang; K Qing; S Ponnazhagan; A Srivastava
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

6.  A novel terminal resolution-like site in the adeno-associated virus type 2 genome.

Authors:  X S Wang; A Srivastava
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

7.  Transcriptional transactivation of parvovirus B19 promoters in nonpermissive human cells by adenovirus type 2.

Authors:  S Ponnazhagan; M J Woody; X S Wang; S Z Zhou; A Srivastava
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

8.  Suppression of human alpha-globin gene expression mediated by the recombinant adeno-associated virus 2-based antisense vectors.

Authors:  S Ponnazhagan; M L Nallari; A Srivastava
Journal:  J Exp Med       Date:  1994-02-01       Impact factor: 14.307

9.  Adeno-associated virus 2-mediated high efficiency gene transfer into immature and mature subsets of hematopoietic progenitor cells in human umbilical cord blood.

Authors:  S Z Zhou; S Cooper; L Y Kang; L Ruggieri; S Heimfeld; A Srivastava; H E Broxmeyer
Journal:  J Exp Med       Date:  1994-06-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.